CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Cumulative Oramed Pharmaceuticals Inc 's Leverage Ratio for Trailing Twelve Months Period

ORMP's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth



ORMP Leverage Ratio for Trailing Twelve Months Period

(May 31 2020)
III. Quarter
(Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
Y / Y Equity Growth 58.24 % -36.52 % -40.54 % -37.67 % 29.42 %
Y / Y Total Liabilities Growth 321.96 % 399.89 % 314.83 % -6.23 % -84.26 %
Leverage Ratio for Trailing Twelve Months Period 0.63 0.62 0.42 0.25 0.24
Total Ranking # 193 # 1240 # 1400 # 1160 # 1122
Seq. Equity Growth 112.01 % -6.24 % -11.51 % -10.04 % -14.96 %
Seq. Total Liabilities Growth -12.69 % -1.33 % -9.13 % 439 % 3.43 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Despite debt repayement of -12.69% in III. Quarter, Leverage Ratio for Trailing Twelve Months Period improved to 0.63, below Oramed Pharmaceuticals Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 16 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Oramed Pharmaceuticals Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 193, from total ranking in previous quarter at 1240.

What is Leverage Ratio?
Who are ORMP's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 17
Sector # 46
S&P 500 # 193


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.95 0.76 0.59
(Nov 30 2017)   (May 31 2019)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending May 31 2020, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Mylan N v   1.64 
Tocagen Inc  1.61 
Xeris Pharmaceuticals Inc   1.57 
Fulcrum Therapeutics Inc   1.57 
Stealth Biotherapeutics Corp  1.56 
Contrafect Corp  1.56 
Biodelivery Sciences International Inc   1.55 
Pfizer Inc  1.53 
Fresenius Medical Care Ag & Co. Kgaa  1.49 
Insmed Inc  1.49 
Gb Sciences Inc  1.48 
Zosano Pharma Corp  1.47 
Lipocine Inc   1.43 
Ampio Pharmaceuticals inc   1.42 
Progenics Pharmaceuticals Inc  1.38 
Johnson and Johnson  1.38 
Celsion Corp  1.37 
Bellerophon Therapeutics Inc   1.33 
Clearside Biomedical Inc   1.31 
Pacira Biosciences inc   1.28 
Grifols Sa  1.27 
Harrow Health Inc   1.25 
Avid Bioservices Inc   1.24 
Cambrex Corp  1.23 
Ani Pharmaceuticals Inc  1.23 
Apellis Pharmaceuticals inc   1.22 
Amag Pharmaceuticals inc   1.21 
Fibrocell Science, Inc.  1.19 
Corbus Pharmaceuticals Holdings Inc   1.18 
Innoviva inc   1.16 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ISRG's Profile

Stock Price

ISRG's Financials

Business Description

Fundamentals

Charts & Quotes

ISRG's News

Suppliers

ISRG's Competitors

Customers & Markets

Economic Indicators

ISRG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071